Medpace Holdings, Inc. (MEDP)
NMS · Healthcare · Diagnostics & Research
Closing price as of 2026-07-29 · Source: TEK2day Finance
Key Metrics
About Medpace Holdings, Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 659.9M | 708.5M | 706.6M | 707.3M |
| Gross Profit | 196.9M | 205.3M | 196.3M | 201.6M |
| Operating Income | 141.8M | 153.3M | 141.5M | 146.8M |
| Net Income | 111.1M | 135.1M | 123.9M | 121.4M |
| Diluted EPS | $3.86 | $4.67 | $4.28 | $4.25 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 1.5B | 1.9B | 2.1B | 2.5B |
| Gross Profit | 432.4M | 524.5M | 656.3M | 760.6M |
| Operating Income | 278.7M | 336.8M | 446.9M | 534.9M |
| Net Income | 245.4M | 282.8M | 404.4M | 451.1M |
| Diluted EPS | $7.28 | $8.88 | $12.63 | $15.28 |